FSD Pharma
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of FSD Pharma generated cash of -$11,025,823, which is more than the previous year. Cash used in financing activities reached the amount of -$3,183,926 last year. Net change in cash is therefore -$14,229,839.
Cash Flow
| 2015 | -63 | 0 | 0 |
|---|---|---|---|
| 2016 | -27.23K | 0 | 34.37K |
| 2017 | -119.17K | -6.08M | 9.95M |
| 2018 | -13.57M | -7.33M | 32.94M |
| 2019 | -13.95M | -234.95K | 4.08M |
| 2020 | -19.13M | 6.51M | 24.17M |
| 2021 | -20.74M | 268.96K | 38.21M |
| 2022 | -28.33M | 12.12M | -2.06M |
| 2023 | -11.02M | -274.52K | -3.18M |
HUGE Cash Flow Statement (2015 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 16.97M | 35.25M | 17.52M | 5.96M | 16.17M | 3.48M | 23.92K | -1 | 63 |
Operating activities | |||||||||
Net income | -18.56M | -26.70M | -33.93M | -28.45M | -39.81M | -16.67M | -2.80M | -29.62K | -32.8K |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||||||
Depreciation and amortization | 2.55M | 4.53M | 4.04M | 3.90M | 2.40M | 134.5K | 0 | 0 | 0 |
Stock-based compensation expense | 3.83M | 1.53M | 7.44M | 8.05M | 12.29M | 0 | 2.37M | 0 | 0 |
| Deferred income tax benefit | 3.83M | 1.53M | 7.44M | 8.05M | 12.29M | 0 | 2.37M | 0 | 0 |
| Changes in operating assets and liabilities: | |||||||||
Accounts receivable, net | -742.08K | -6.93M | -105.93K | 458.17K | -1.07M | 0 | 0 | 0 | 0 |
Inventories | 0 | -282.12K | 25.41K | -42.63K | -721.85K | 0 | 0 | 0 | 0 |
Accounts payable | 2.08M | -672.05K | 3.57M | 946.16K | 825.12K | 318.46K | 790.97K | -8.86K | 12.62K |
Cash generated by operating activities | -11.02M | -28.33M | -20.74M | -19.13M | -13.95M | -13.57M | -119.17K | -27.23K | -63 |
Investing activities | |||||||||
Purchases Of Investments | -758.15K | -401.61K | 0 | 0 | 298.28K | -5.87M | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -31.78K | -363.95K | -500K | 0 | -707.17K | -2.96M | -6.08M | 0 | 0 |
Acquisitions Net | 31.78K | 0 | 768.96K | 0 | 1.78K | 1.49M | 0 | 0 | 0 |
Cash generated by investing activities | -274.52K | 12.12M | 268.96K | 6.51M | -234.95K | -7.33M | -6.08M | 0 | 0 |
Financing activities | |||||||||
Common Stock Issued | 34 | 0 | 38.34M | 25.10M | 3.51M | 33.02M | 10.96M | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | -2.95M | -1.92M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | -189.05K | -143.07K | -129.32K | -986.63K | 0 | 0 | 0 | -13.75K | 0 |
Cash used in financing activities | -3.18M | -2.06M | 38.21M | 24.17M | 4.08M | 32.94M | 9.95M | 34.37K | 0 |
Net Change In Cash | -14.22M | -18.27M | 17.73M | 11.55M | -10.10M | 12.03M | 3.74M | 7.13K | -63 |
Cash at end of period | 2.74M | 16.98M | 35.25M | 17.52M | 6.07M | 15.51M | 3.76M | 7.13K | 0 |
| Data source | Data source | Data source |